The emerging approach of this peptide represents a exciting development in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide106468.prublogger.com/40827408/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment